Fiorella Ilariucci

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 656 citations · Full text

Hematological Malignancy, Neuro-oncology, Lymphoid Neoplasia +9

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 364 citations · Full text

Neuro-oncology, Radiation Oncology, Lymphoid Neoplasia +12

Temozolomide as salvage treatment in primary brain lymphomas

Michele Reni, Francesco Zaja, Warren Mason et al. · British Journal of Cancer · 2007 · 178 citations · Full text

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · Leukemia · 2022 · 146 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Transplantation +9

Low-Dose Thalidomide Ameliorates Cytopenias and Splenomegaly in Myelofibrosis With Myeloid Metaplasia: A Phase II Trial

Monia Marchetti, Giovanni Barosi, Francesca Balestri et al. · Journal of Clinical Oncology · 2004 · 144 citations